RhumbLine Advisers’s Cano Health, Inc. CANO Stock Holding History

RhumbLine Advisers’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,099	Closed	-$78.7K	–	4312
2023 Q3	$78.7K	Sell	3,099 -2,287	-42%	-$188K	﹤0.01%	3536
2023 Q2	$749K	Buy	5,386 +3,389	+170%	+$435K	﹤0.01%	2451
2023 Q1	$182K	Buy	1,997 +59	+3%	+$8.01K	﹤0.01%	2757
2022 Q4	$265K	Buy	1,938 +26	+1%	+$8.8K	﹤0.01%	2717
2022 Q3	$1.66M	Buy	1,912 +148	+8%	+$92.8K	﹤0.01%	1860
2022 Q2	$773K	Buy	+1,764	New	+$920K	﹤0.01%	2265

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RhumbLine Advisers's CANO Position: Q4 2023 in Review

RhumbLine Advisers sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 3,099 shares — an estimated $78.7K sold.

RhumbLine Advisers first reported a position in CANO in Q2 2022 and held it in 6 quarters. The position peaked at $1.66M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

RhumbLine Advisers reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
RhumbLine Advisers sold 3,099 Cano Health, Inc. shares in Q4 2023, an estimated $78.7K.
RhumbLine Advisers first reported a position in Cano Health, Inc. in Q2 2022 and held it in 6 quarters.
RhumbLine Advisers's Cano Health, Inc. position peaked at $1.66M in Q3 2022.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.